Literature DB >> 19602789

Donepezil-induced adverse side effects of cardiac rhythm: 2 cases report of atrioventricular block and Torsade de Pointes.

Atsushi Tanaka1, Shoichi Koga, Yoshihiro Hiramatsu.   

Abstract

Acetylcholinesterase inhibitors (AChIs) are widely used in the treatment of mild-to-moderate Alzheimer's disease (AD), but their cholinergic effects could generate adverse side effects in the cardiovascular system. This report presents the cases of 2 patients who experienced adverse side effects of cardiac rhythm with QT prolongation caused by Donepezil. Both of them improved to the original rhythm and shortened QT intervals after the discontinuation of Donepezil. The present cases suggest that the cholinergic effects of Donepezil could induce adverse side effects on cardiac rhythm and careful consideration is needed for the patients treated by Donepezil.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602789     DOI: 10.2169/internalmedicine.48.2181

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  13 in total

Review 1.  Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.

Authors:  Galia Jackobson; Narin Nard Carmel; Dor Lotan; Anjelika Kremer; Dan Justo
Journal:  Z Gerontol Geriatr       Date:  2016-11-22       Impact factor: 1.281

2.  A case of donepezil-related torsades de pointes.

Authors:  Jamie Kitt; Robert Irons; Mohamed Al-Obaidi; Constantinos Missouris
Journal:  BMJ Case Rep       Date:  2015-10-05

3.  Risk Factors for Cardiovascular Events in Patients on Antidementia Medications.

Authors:  Meiqi He; James M Stevenson; Yuting Zhang; Inmaculada Hernandez
Journal:  Am J Alzheimers Dis Other Demen       Date:  2020 Jan-Dec       Impact factor: 2.035

4.  QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine.

Authors:  Katie Malone; Jules C Hancox
Journal:  Ther Adv Drug Saf       Date:  2020-08-17

Review 5.  Cardiovascular effects of drugs used to treat Alzheimer's disease.

Authors:  Laurence Guy Howes
Journal:  Drug Saf       Date:  2014-06       Impact factor: 5.606

Review 6.  Heart Failure and Cognitive Impairment: Clinical Relevance and Therapeutic Considerations.

Authors:  Tuoyo O Mene-Afejuku; Monica Pernia; Uzoma N Ibebuogu; Shobhana Chaudhari; Savi Mushiyev; Ferdinand Visco; Gerald Pekler
Journal:  Curr Cardiol Rev       Date:  2019

Review 7.  Heart failure and Alzheimer's disease.

Authors:  P Cermakova; M Eriksdotter; L H Lund; B Winblad; P Religa; D Religa
Journal:  J Intern Med       Date:  2014-08-01       Impact factor: 8.989

8.  Inhibitory effects of cholinesterase inhibitor donepezil on the Kv1.5 potassium channel.

Authors:  Kai Li; Neng Cheng; Xian-Tao Li
Journal:  Sci Rep       Date:  2017-02-13       Impact factor: 4.379

9.  Electrocardiogram Changes of Donepezil Administration in Elderly Patients with Ischemic Heart Disease.

Authors:  Deguo Wang; Yong Wu; Ancai Wang; Yueyun Chen; Ting Zhang; Nengwei Hu
Journal:  Cardiol Res Pract       Date:  2018-04-23       Impact factor: 1.866

10.  In Vitro Metabolism of Donepezil in Liver Microsomes Using Non-Targeted Metabolomics.

Authors:  Sin-Eun Kim; Hyung-Ju Seo; Yeojin Jeong; Gyung-Min Lee; Seung-Bae Ji; So-Young Park; Zhexue Wu; Sangkyu Lee; Sunghwan Kim; Kwang-Hyeon Liu
Journal:  Pharmaceutics       Date:  2021-06-23       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.